Corbus Pharmaceuticals Stock Surges Ahead of Drug Data Readout
By Kelly CloonanShares of Corbus Pharmaceuticals rallied after the company said it would host a webcast to discuss topline data for a study for an obesity treatment.The stock was up 20% to $9.75 in late trading on Friday. At market close shares were roughly flat year to date.Corbus said the webcast…